A Study to Evaluate the Safety, Tolerability, PK and Preliminary Efficacy of HX15001 Combined With Etrasimod in Moderate-severe Ulcerative Colitis

Clinical trial NCT07768254 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07768254
Sponsor: Helixon Biotechnology (Suzhou) Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2026-09-09
Primary completion: 2028-04-15
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.